|
KR20130050877A
|
|
Stabilized and extended release formation of sarpogrelate
|
|
KR20130023127A
|
|
Controlled-release formulations comprising pregabalin
|
|
CN103284970A
|
|
Sarpogrelate hydrochloride sustained release preparation and preparation method thereof
|
|
KR20120068249A
|
|
The process for orally disintegrating tablet of sildenafil and the orally disintegrating tablet manufactured by the process
|
|
KR20120044637A
|
|
Pharmaceutical preparation
|
|
KR20120060983A
|
|
Sustained release dosage form and manufacturing procedure of Sarpogrelate HCl
|
|
KR20120021483A
|
|
Pharmaceutical composition containing antidepressant
|
|
KR20120012716A
|
|
Pharmaceutical composition containing andtidepressant
|
|
KR20120021455A
|
|
Sustained release preparation comprising itopride and preparation method thereof
|
|
KR20110097168A
|
|
New pharmaceutical composition for treatment of hyperlipidemia
|
|
KR20110090142A
|
|
New pharmaceutical composition which has sustained release profiles
|
|
KR20110067302A
|
|
Pharmaceutical formulation
|
